Sandra Milligan
Net worth: 8 947 $ as of 2026-09-29
Net worth: 8 947 $ as of 2026-09-29
Ms. Sandra Milligan is an Independent Director at Gossamer Bio, Inc. and a Head-Research & Development at Organon & Co. She is on the Board of Directors at Gossamer Bio, Inc. Ms. Milligan was previously employed as a Vice President-Regulatory Affairs by Genentech, Inc. She received her undergraduate degree from the University of California, Irvine, a graduate degree from Georgetown University Law Center and a doctorate degree from George Washington University School of Medicine & Health.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GOSSAMER BIO, INC. 0.01% | 2026-09-22 | 755 ( 0.01% ) | 8 947 $ | 2026-09-29 |
| 2026-05-26 | 0 ( -.--% ) | - $ | 2026-09-29 |
| Companies | Position | Start |
|---|---|---|
| GOSSAMER BIO, INC. | Director/Board Member | 2021-06-09 |
| SPYRE THERAPEUTICS, INC. | Director/Board Member | 2024-05-14 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Corporate Officer/Principal | 2025-01-31 |
| Companies | Position | End |
|---|---|---|
| ASPIRA WOMEN'S HEALTH INC. | Chief Executive Officer | 2025-01-27 |
| ORGANON & CO. | Chief Tech/Sci/R&D Officer | 2023-12-31 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 2020-03-31 |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services Operates as non-profit multidisciplinary association for health and well-being | Director/Board Member | 2016-12-31 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 2014-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 13 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Aspira Women's Health, Inc.
Aspira Women's Health, Inc. BiotechnologyHealth Technology Develops and manufactures diagnostic test kits | Health Technology |
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services Operates as non-profit multidisciplinary association for health and well-being | Commercial Services |
The United States Army Medical Service Corps | |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Georgetown University Law Center
Georgetown University Law Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gossamer Bio, Inc.
Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
George Washington University School of Medicine & Health
George Washington University School of Medicine & Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organon & Co.
Organon & Co. Pharmaceuticals: MajorHealth Technology Develops and delivers women health, trusted legacy brands and therapeutics | Health Technology |
Select your edition
All financial news and data tailored to specific country editions